Biological material for biomarker research in spondyloarthritis: mapping the availability in European rheumatology registries-Reference-Cited by-同舟云学术

Biological material for biomarker research in spondyloarthritis: mapping the availability in European rheumatology registries

Published:2024-07-30 Issue: Volume: Page:
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Glintborg Bente¹²^ORCID,Østergaard Mikkel²³^ORCID,Jørgensen Jacob Brauner³,Wallman Johan K⁴^ORCID,Möller Burkhard⁵^ORCID,Nissen Michael J⁶^ORCID,Michelsen Brigitte⁷,Sexton Joseph⁷,Ørnbjerg Lykke Midtbøll³^ORCID,Hetland Merete Lund²³^ORCID

Affiliation:

1. DANBIO, The Danish Rheumatologic Biobank and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet , Glostrup, Denmark

2. Department of Clinical Medicine, University of Copenhagen , Copenhagen, Denmark

3. Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet , Glostrup, Denmark

4. Department of Clinical Sciences Lund, Rheumatology, Skåne University Hospital, Lund University , Lund, Sweden

5. Department Rheumatology and Immunology, Inselspital—University Hospital Bern , Bern, Switzerland

6. Department of Rheumatology, Geneva University Hospital , Geneva, Switzerland

7. Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital , Oslo, Norway

Funder

Novartis Pharma AG

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keae369/58821231/keae369.pdf

Reference8 articles.

1. Machine learning techniques for personalised medicine approaches in immune-mediated chronic inflammatory diseases: applications and challenges;Peng;Front Pharmacol,2021

2. Genetic and molecular distinctions between axial psoriatic arthritis and radiographic axial spondyloarthritis: post hoc analyses from four phase 3 clinical trials;Kavanaugh;Adv Ther,2023

3. Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis;FitzGerald;Ther Adv Musculoskelet Dis,2023

4. Commonalities and differences in set-up and data collection across European spondyloarthritis registries—results from the EuroSpA collaboration;Linde;Arthritis Res Ther,2023

5. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort;Olofsson;Rheumatology (Oxford),2019